Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesCardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
JAMA, 10/29/09
Jager DJD et al. – Patients starting dialysis have a generally increased risk of death that is not specifically caused by excess cardiovascular mortality.
Related Articles
Engagement in cultural activities and cause-specific mortality: Prospective cohort study
Preventive Medicine, 10/20/09
Relevance Score: 92%
Childhood cancer mortality in Europe, 1970–2007
European Journal of Cancer, 10/14/09
Relevance Score: 91%
Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event
Cochrane Reviews, 10/27/09
Relevance Score: 90%
Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality
Preventive Medicine, 10/16/09
Relevance Score: 90%
Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries
International Journal of Epidemiology, 10/12/09
Relevance Score: 90%
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Plasma Ghrelin Levels Are Associated with Coronary Microvascular and Endothelial Dysfunction in Peritoneal Dialysis Patients
Renal Failure, 11/25/09
Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins
Renal Failure, 11/25/09
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
Nephrology Dialysis Transplantation, 11/24/09
Article Search
Sponsor